Literature DB >> 10559649

Low levels of high-density lipoprotein cholesterol are a marker of disability in the elderly.

G Zuliani1, F Romagnoni, C Bollini, V Leoci, L Soattin, R Fellin.   

Abstract

BACKGROUND: In the elderly, high-density lipoprotein cholesterol (HDL-C) seems to have further clinical meanings besides the inverse relationship with coronary heart disease (CHD); indeed, low values have been found in elderly subjects with functional disability, chronic illness, and in severe clinical conditions.
OBJECTIVE: To verify the hypothesis that low HDL-C might be a 'marker' for disability, we evaluated the relationship between lipoprotein parameters and functional status, over a period of 2 years, in a large sample of institutionalized elderly.
METHODS: 344 institutionalized subjects aged over 65 years were studied. They were divided into two groups according to basal disability level: 'low-mild': class A-E, and 'high': class F-G of the Katz index. 124 survivors, independent in at least two basic activities of daily living (BADL) at enrollment, were divided into two groups on the basis of 2 years' modifications in functional status: stable/improved or worsened (lost >/=2 BADL).
RESULTS: Total cholesterol, LDL-C, HDL-C, and apo A-I levels were lower in the high disability group, while no differences in triglycerides and apo B levels emerged. Multiple logistic regression analysis showed that severe disability was associated with HDL-C (II vs. III tertile: OR 2.01; CI 95% 1.04-3.91; I vs. III tertile: OR 2.52; CI 95% 1.23-5. 15), total cholesterol (I vs. III tertile: OR 2.35; CI 95% 1.14-4. 81), blood glucose (OR 0.98), and body mass index (OR 0.91), independently from uric acid, number of pathologies, number of drugs, body cell mass, vitamin B(12) and folic acid plasma levels, waist/hip ratio, age, and gender. Subjects who lost >/=2 BADL in the 2-year follow-up consistently showed lower basal HDL-C levels compared to subjects with stable/improved functional status, and this difference was significant after adjustment for basal Katz class, age, gender, number of pathologies, blood glucose, body mass index, and waist/hip ratio.
CONCLUSIONS: The results of this study suggest that in the elderly severe disability is strongly associated with low HDL-C levels. Longitudinal data support the hypothesis that low HDL-C might be considered as a marker for 'ongoing' disability in BADL. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559649     DOI: 10.1159/000022112

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  14 in total

1.  Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.

Authors:  G Zuliani; M Cavalieri; M Galvani; S Volpato; A Cherubini; S Bandinelli; A M Corsi; F Lauretani; J M Guralnik; R Fellin; L Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-18       Impact factor: 6.053

2.  Metabolic syndrome predicts incident disability and functional decline among Chinese older adults: results from the China Health and Retirement Longitudinal Study.

Authors:  Quan Zhang; Yi Wang; Nan Yu; Hua Ding; Danyu Li; Xinyi Zhao
Journal:  Aging Clin Exp Res       Date:  2021-03-20       Impact factor: 3.636

3.  Serum high-density lipoprotein cholesterol levels correlate well with functional but not with cognitive status in 85-year-old subjects.

Authors:  F Formiga; A Ferrer; D Chivite; X Pinto; T Badia; G Padrós; R Pujol
Journal:  J Nutr Health Aging       Date:  2012-05       Impact factor: 4.075

4.  The Association Between Lipoproteins, Disability, and Physical Function Among Older Costa Rican Adults.

Authors:  Marianne Chanti-Ketterl; Alyssa Gamaldo; Ross Andel; Roland J Thorpe
Journal:  J Aging Health       Date:  2017-02-01

5.  Nutritional determination of the health status in Polish elderly people from an urban environment.

Authors:  J Wyka; J Biernat; D Kiedik
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

6.  High-density lipoprotein cholesterol and objective measures of lower extremity performance in older nondisabled persons: the InChianti study.

Authors:  Stefano Volpato; Alessandro Ble; E Jeffrey Metter; Fulvio Lauretani; Stefania Bandinelli; Giovanni Zuliani; Renato Fellin; Luigi Ferrucci; Jack M Guralnik
Journal:  J Am Geriatr Soc       Date:  2008-01-16       Impact factor: 5.562

7.  Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men.

Authors:  Alexander M Kulminski; Svetlana V Ukraintseva; Konstantin G Arbeev; Kenneth G Manton; Junko Oshima; George M Martin; Dora Il'yasova; Anatoli I Yashin
Journal:  J Am Geriatr Soc       Date:  2008-01-04       Impact factor: 5.562

8.  Myeloperoxidase levels and mortality in frail community-living elderly individuals.

Authors:  Silvia Giovannini; Graziano Onder; Christiaan Leeuwenburgh; Christy Carter; Emanuele Marzetti; Andrea Russo; Ettore Capoluongo; Marco Pahor; Roberto Bernabei; Francesco Landi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-01-11       Impact factor: 6.053

9.  Association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphism and disability severity in a national long-term care survey sample.

Authors:  Alexander Kulminski; Svetlana V Ukraintseva; Konstantin G Arbeev; Kenneth G Manton; Junko Oshima; George M Martin; Anatoli I Yashin
Journal:  Age Ageing       Date:  2008-02-04       Impact factor: 10.668

10.  Association between the metabolic syndrome and its components and gait speed among U.S. adults aged 50 years and older: a cross-sectional analysis.

Authors:  Catherine A Okoro; Yuna Zhong; Earl S Ford; Lina S Balluz; Tara W Strine; Ali H Mokdad
Journal:  BMC Public Health       Date:  2006-11-14       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.